These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Accuracy of tissue polypeptide specific antigen (TPS) in the diagnosis of ovarian malignancy. Padungsutt P; Thirapagawong C; Senapad S; Suphanit I Anticancer Res; 2000; 20(2B):1291-5. PubMed ID: 10810437 [TBL] [Abstract][Full Text] [Related]
7. Serum tissue polypeptide specific antigen as a noninvasive prognostic indicator for early recurrence of hepatocellular carcinoma after curative resection. Yao WJ; Wang ST; Chow NH; Chang TT; Lin PW; Tu DG Cancer; 2002 Jul; 95(1):112-8. PubMed ID: 12115324 [TBL] [Abstract][Full Text] [Related]
8. Comparative analysis of CA125, tissue polypeptide specific antigen, and soluble interleukin-2 receptor alpha levels in sera, cyst, and ascitic fluids from patients with ovarian carcinoma. Sedlaczek P; Frydecka I; Gabryś M; Van Dalen A; Einarsson R; Harłozińska A Cancer; 2002 Nov; 95(9):1886-93. PubMed ID: 12404282 [TBL] [Abstract][Full Text] [Related]
9. TPS and CA 125 levels in serum, cyst fluid and ascites of patients with epithelial ovarian neoplasms. Harłozinska A; Sedlaczek P; Van Dalen A; Rozdolski K; Einarsson R Anticancer Res; 1997; 17(6D):4473-8. PubMed ID: 9494553 [TBL] [Abstract][Full Text] [Related]
10. Tissue polypeptide specific antigen (TPS) and carbohydrate antigen 125 (CA-125) in the early prediction of recurrent ovarian cancer. Yeh LS; Hung YC; Kao A; Lin CC; Lee CC Anticancer Res; 2002; 22(6B):3669-71. PubMed ID: 12552974 [TBL] [Abstract][Full Text] [Related]
11. Serum C-reactive protein in the differential diagnosis of ovarian masses. Hefler-Frischmuth K; Hefler LA; Heinze G; Paseka V; Grimm C; Tempfer CB Eur J Obstet Gynecol Reprod Biol; 2009 Nov; 147(1):65-8. PubMed ID: 19619929 [TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of CA 125 and TPS levels after 3 chemotherapy courses in ovarian cancer patients. van Dalen A; Favier J; Burges A; Hasholzner U; de Bruijn HW; Dobler-Girdziunaite D; Dombi VH; Fink D; Giai M; McGing P; Harlozinska A; Kainz C; Markowska J; Molina R; Sturgeon C; Bowman A; Einarsson R Gynecol Oncol; 2000 Dec; 79(3):444-50. PubMed ID: 11104617 [TBL] [Abstract][Full Text] [Related]
13. [The clinical value of tissue polypeptide antigen in ovarian carcinoma]. Wu L; Sun J; Wang X Zhonghua Fu Chan Ke Za Zhi; 1998 Feb; 33(2):92-4. PubMed ID: 10682428 [TBL] [Abstract][Full Text] [Related]
14. TPS and CA 15.3 serum values as a guide for treating and monitoring breast cancer patients. Giai M; Roagna R; Ponzone R; Biglia N; Sgro L; Perona M; Sismondi P Anticancer Res; 1996; 16(2):875-81. PubMed ID: 8687144 [TBL] [Abstract][Full Text] [Related]
15. Tissue polypeptide specific antigen (tps) and cytokeratin 19 fragment (CYFRA 21.1) immunoradiometric assay in non small cell lung cancer evaluation. Giovanella L; Ceriani L; Bandera M; Rimoldi R; Beghé B; Roncari G Q J Nucl Med; 1995 Dec; 39(4):285-9. PubMed ID: 8624791 [TBL] [Abstract][Full Text] [Related]
16. CYFRA 21-1 serum levels in women with adnexal masses and inflammatory diseases. Tempfer C; Hefler L; Heinzl H; Loesch A; Gitsch G; Rumpold H; Kainz C Br J Cancer; 1998 Oct; 78(8):1108-12. PubMed ID: 9792159 [TBL] [Abstract][Full Text] [Related]
17. A comparative study of mucin-like carcinoma-associated antigen (MCA), CA 125, CA 19-9 and CEA in patients with ovarian cancer. Koelbl H; Schieder K; Neunteufel W; Bieglmayer C Neoplasma; 1989; 36(4):473-8. PubMed ID: 2770933 [TBL] [Abstract][Full Text] [Related]
18. Cytokeratin markers in patients with prostatic diseases. Wolff JM; Borchers H; Brehmer B; Brauers A; Jakse G Anticancer Res; 1999; 19(4A):2649-52. PubMed ID: 10470212 [TBL] [Abstract][Full Text] [Related]
19. Measurement of a monoclonal-antibody-defined antigen (90K) in the sera of patients with ovarian cancer. Scambia G; Panici PB; Baiocchi G; Perrone L; Iacobelli S; Mancuso S Anticancer Res; 1988; 8(4):761-4. PubMed ID: 3178164 [TBL] [Abstract][Full Text] [Related]
20. Prognostic value of CA 125 in ovarian cyst fluid of patients with epithelial ovarian cancer. Kolwijck E; Span PN; Thomas CM; Bulten J; Sweep FC; Massuger LF Oncol Rep; 2010 Feb; 23(2):579-84. PubMed ID: 20043124 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]